Global 23-valent Pneumococcal Vaccine Market Growth 2023-2028

Report ID: 1479601 | Published Date: Oct 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for 23-valent Pneumococcal Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 23-valent Pneumococcal Vaccine Segment by Type
        2.2.1 Single Dose Vial
        2.2.2 Pre-filled Syringe
    2.3 23-valent Pneumococcal Vaccine Sales by Type
        2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022)
    2.4 23-valent Pneumococcal Vaccine Segment by Application
        2.4.1 Chronic Cardiovascular Disease
        2.4.2 Chronic Lung Disease
        2.4.3 Chronic Liver Disease
        2.4.4 People Living with Hiv
        2.4.5 Leukemia
        2.4.6 Lymphoma
        2.4.7 Multiple Myeloma
        2.4.8 General Malignancy
        2.4.9 Chronic Kidney Disease
        2.4.10 Other
    2.5 23-valent Pneumococcal Vaccine Sales by Application
        2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022)
3 Global 23-valent Pneumococcal Vaccine by Company
    3.1 Global 23-valent Pneumococcal Vaccine Breakdown Data by Company
        3.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022)
        3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company
    3.4 Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution
        3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for 23-valent Pneumococcal Vaccine by Geographic Region
    4.1 World Historic 23-valent Pneumococcal Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Geographic Region
    4.2 World Historic 23-valent Pneumococcal Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global 23-valent Pneumococcal Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global 23-valent Pneumococcal Vaccine Annual Revenue by Country/Region
    4.3 Americas 23-valent Pneumococcal Vaccine Sales Growth
    4.4 APAC 23-valent Pneumococcal Vaccine Sales Growth
    4.5 Europe 23-valent Pneumococcal Vaccine Sales Growth
    4.6 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth
5 Americas
    5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country
        5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)
        5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)
    5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type
    5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region
        6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022)
        6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022)
    6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type
    6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe 23-valent Pneumococcal Vaccine by Country
        7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)
        7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)
    7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type
    7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country
        8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type
    8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine
    10.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
    10.4 Industry Chain Structure of 23-valent Pneumococcal Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 23-valent Pneumococcal Vaccine Distributors
    11.3 23-valent Pneumococcal Vaccine Customer
12 World Forecast Review for 23-valent Pneumococcal Vaccine by Geographic Region
    12.1 Global 23-valent Pneumococcal Vaccine Market Size Forecast by Region
        12.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Region (2023-2028)
        12.1.2 Global 23-valent Pneumococcal Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global 23-valent Pneumococcal Vaccine Forecast by Type
    12.7 Global 23-valent Pneumococcal Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck 23-valent Pneumococcal Vaccine Product Offered
        13.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Sanofipasteur
        13.2.1 Sanofipasteur Company Information
        13.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered
        13.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Sanofipasteur Main Business Overview
        13.2.5 Sanofipasteur Latest Developments
    13.3 CDIBP
        13.3.1 CDIBP Company Information
        13.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Offered
        13.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 CDIBP Main Business Overview
        13.3.5 CDIBP Latest Developments
    13.4 Kexing Bio
        13.4.1 Kexing Bio Company Information
        13.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Offered
        13.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Kexing Bio Main Business Overview
        13.4.5 Kexing Bio Latest Developments
    13.5 Changsheng Bio-Technology
        13.5.1 Changsheng Bio-Technology Company Information
        13.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered
        13.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Changsheng Bio-Technology Main Business Overview
        13.5.5 Changsheng Bio-Technology Latest Developments
    13.6 Huaan Science and Technology Innovation
        13.6.1 Huaan Science and Technology Innovation Company Information
        13.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered
        13.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Huaan Science and Technology Innovation Main Business Overview
        13.6.5 Huaan Science and Technology Innovation Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. 23-valent Pneumococcal Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Single Dose Vial
    Table 4. Major Players of Pre-filled Syringe
    Table 5. Global 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
    Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
    Table 7. Global 23-valent Pneumococcal Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 8. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)
    Table 9. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
    Table 10. Global 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
    Table 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Table 12. Global 23-valent Pneumococcal Vaccine Revenue by Application (2017-2022)
    Table 13. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2017-2022)
    Table 14. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
    Table 15. Global 23-valent Pneumococcal Vaccine Sales by Company (2020-2022) & (K Units)
    Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2020-2022)
    Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2020-2022)
    Table 19. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
    Table 20. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area
    Table 21. Players 23-valent Pneumococcal Vaccine Products Offered
    Table 22. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global 23-valent Pneumococcal Vaccine Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global 23-valent Pneumococcal Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 27. Global 23-valent Pneumococcal Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global 23-valent Pneumococcal Vaccine Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global 23-valent Pneumococcal Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 31. Global 23-valent Pneumococcal Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
    Table 34. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
    Table 35. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
    Table 37. Americas 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
    Table 38. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
    Table 39. Americas 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
    Table 40. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Table 41. APAC 23-valent Pneumococcal Vaccine Sales by Region (2017-2022) & (K Units)
    Table 42. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)
    Table 43. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2017-2022)
    Table 45. APAC 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
    Table 46. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
    Table 47. APAC 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
    Table 48. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Table 49. Europe 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
    Table 50. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
    Table 51. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
    Table 53. Europe 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
    Table 54. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
    Table 55. Europe 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
    Table 56. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of 23-valent Pneumococcal Vaccine
    Table 66. Key Market Challenges & Risks of 23-valent Pneumococcal Vaccine
    Table 67. Key Industry Trends of 23-valent Pneumococcal Vaccine
    Table 68. 23-valent Pneumococcal Vaccine Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. 23-valent Pneumococcal Vaccine Distributors List
    Table 71. 23-valent Pneumococcal Vaccine Customer List
    Table 72. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global 23-valent Pneumococcal Vaccine Sales Market Forecast by Region
    Table 74. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck 23-valent Pneumococcal Vaccine Product Offered
    Table 94. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 98. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered
    Table 99. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 100. Sanofipasteur Main Business
    Table 101. Sanofipasteur Latest Developments
    Table 102. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 103. CDIBP 23-valent Pneumococcal Vaccine Product Offered
    Table 104. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 105. CDIBP Main Business
    Table 106. CDIBP Latest Developments
    Table 107. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 108. Kexing Bio 23-valent Pneumococcal Vaccine Product Offered
    Table 109. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 110. Kexing Bio Main Business
    Table 111. Kexing Bio Latest Developments
    Table 112. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 113. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered
    Table 114. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 115. Changsheng Bio-Technology Main Business
    Table 116. Changsheng Bio-Technology Latest Developments
    Table 117. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 118. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered
    Table 119. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
    Table 120. Huaan Science and Technology Innovation Main Business
    Table 121. Huaan Science and Technology Innovation Latest Developments
List of Figures
    Figure 1. Picture of 23-valent Pneumococcal Vaccine
    Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Single Dose Vial
    Figure 10. Product Picture of Pre-filled Syringe
    Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2021
    Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2017-2022)
    Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease
    Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2017-2022) & (K Units)
    Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease
    Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2017-2022) & (K Units)
    Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease
    Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2017-2022) & (K Units)
    Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv
    Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2017-2022) & (K Units)
    Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia
    Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2017-2022) & (K Units)
    Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma
    Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2017-2022) & (K Units)
    Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma
    Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2017-2022) & (K Units)
    Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy
    Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2017-2022) & (K Units)
    Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease
    Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2017-2022) & (K Units)
    Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other
    Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2017-2022) & (K Units)
    Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2017-2022)
    Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2021
    Figure 35. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 36. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2021
    Figure 37. Global 23-valent Pneumococcal Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2017-2022)
    Figure 40. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Country/Region in 2021
    Figure 41. Americas 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
    Figure 42. Americas 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
    Figure 43. APAC 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
    Figure 44. APAC 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
    Figure 45. Europe 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
    Figure 46. Europe 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
    Figure 47. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2017-2022 (K Units)
    Figure 48. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2017-2022 ($ Millions)
    Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021
    Figure 50. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
    Figure 51. United States 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2021
    Figure 56. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2021
    Figure 57. China 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Korea 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. India 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021
    Figure 64. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
    Figure 65. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 66. France 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 67. UK 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 68. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 69. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 70. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2021
    Figure 71. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2021
    Figure 72. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 73. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 74. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 75. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 76. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 77. Manufacturing Cost Structure Analysis of 23-valent Pneumococcal Vaccine in 2021
    Figure 78. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
    Figure 79. Industry Chain Structure of 23-valent Pneumococcal Vaccine
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global 23-valent Pneumococcal Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global 23-valent Pneumococcal Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global 23-valent Pneumococcal Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports